Orchard, Paul A. et al "Patients with Inherited Metabolic Disorders (IMD) transplanted with MGTA-456, a CD34+ Expanded Cell Therapy Product, Show Rapid Engraftment in Preliminary Phase 2 Trial Results (P4.6-059)." Neurology 92.15 Supplement (2019): P4.6-059. Web. 06 Oct. 2022.